These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31052360)

  • 21. Antileishmanial Agents Co-loaded in Transfersomes with Enhanced Macrophage Uptake and Reduced Toxicity.
    Zahid F; Batool S; Ud-Din F; Ali Z; Nabi M; Khan S; Salman O; Khan GM
    AAPS PharmSciTech; 2022 Aug; 23(6):226. PubMed ID: 35970966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis.
    Riezk A; Van Bocxlaer K; Yardley V; Murdan S; Croft SL
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32887341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel and safe single-dose treatment of cutaneous leishmaniasis with implantable amphotericin B-loaded microparticles.
    Sousa-Batista AJ; Pacienza-Lima W; Ré MI; Rossi-Bergmann B
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():148-155. PubMed ID: 31331828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local amphotericin B therapy for Cutaneous Leishmaniasis: A systematic review.
    Alves LL; Freire ML; Troian IL; Morais-Teixeira E; Cota G
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012127. PubMed ID: 38626196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphotericin B-Loaded Extracellular Vesicles Derived from
    Davari A; Hajjaran H; Khamesipour A; Mohebali M; Mehryab F; Shahsavari S; Shekari F
    Iran J Parasitol; 2023; 18(4):514-525. PubMed ID: 38169565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.
    Guery R; Henry B; Martin-Blondel G; Rouzaud C; Cordoliani F; Harms G; Gangneux JP; Foulet F; Bourrat E; Baccard M; Morizot G; Consigny PH; Berry A; Blum J; Lortholary O; Buffet P;
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006094. PubMed ID: 29155816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gel characterisation and in vivo evaluation of minocycline-loaded wound dressing with enhanced wound healing using polyvinyl alcohol and chitosan.
    Sung JH; Hwang MR; Kim JO; Lee JH; Kim YI; Kim JH; Chang SW; Jin SG; Kim JA; Lyoo WS; Han SS; Ku SK; Yong CS; Choi HG
    Int J Pharm; 2010 Jun; 392(1-2):232-40. PubMed ID: 20230884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topically Applied Chitosan-Coated Poly(isobutylcyanoacrylate) Nanoparticles Are Active Against Cutaneous Leishmaniasis by Accelerating Lesion Healing and Reducing the Parasitic Load.
    Malli S; Pomel S; Ayadi Y; Deloménie C; Da Costa A; Loiseau PM; Bouchemal K
    ACS Appl Bio Mater; 2019 Jun; 2(6):2573-2586. PubMed ID: 35030712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery.
    Vásquez Marcano RGDJ; Tominaga TT; Khalil NM; Pedroso LS; Mainardes RM
    Carbohydr Polym; 2018 Dec; 202():345-354. PubMed ID: 30287009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoemulsions containing amphotericin b and paromomycin for the treatment of cutaneous leishmaniasis.
    Cunha NFC; de Siqueira LBO; Garcia AR; Rodrigues IA; Matos APDS; Júnior ER; Monteiro MSSB
    Acta Trop; 2024 Jun; 254():107189. PubMed ID: 38522630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases.
    Fernández-García R; Statts L; de Jesus JA; Dea-Ayuela MA; Bautista L; Simão R; Bolás-Fernández F; Ballesteros MP; Laurenti MD; Passero LFD; Lalatsa A; Serrano DR
    ACS Infect Dis; 2020 Oct; 6(10):2647-2660. PubMed ID: 32810398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial hydrogels based on PVA and diphlorethohydroxycarmalol (DPHC) derived from brown alga Ishige okamurae: An in vitro and in vivo study for wound dressing application.
    Kim MS; Oh GW; Jang YM; Ko SC; Park WS; Choi IW; Kim YM; Jung WK
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110352. PubMed ID: 31761165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of in vitro and in vivo Efficacy of a Novel Amphotericin B-Loaded Nanostructured Lipid Carrier in the Treatment of
    Rebouças-Silva J; Tadini MC; Devequi-Nunes D; Mansur AL; S Silveira-Mattos P; I de Oliveira C; R Formiga F; Berretta AA; Marquele-Oliveira F; Borges VM
    Int J Nanomedicine; 2020; 15():8659-8672. PubMed ID: 33177824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of pediatric cutaneous leishmaniasis with liposomal amphotericin B.
    Erat T; An I
    Dermatol Ther; 2022 Sep; 35(9):e15706. PubMed ID: 35810338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B:
    Mahfud MAS; Syahirah NA; Akram M; Mahfufah U; Saputra MD; Elim D; Andi MNF; Sultan NAF; Himawan A; Domínguez-Robles J; Pamornpathomkul B; Mir M; Permana AD
    Mol Pharm; 2023 Dec; 20(12):6246-6261. PubMed ID: 37975721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the in vivo leishmanicidal activity of amphotericin B emulgel: An alternative for the treatment of skin leishmaniasis.
    Pinheiro IM; Carvalho IP; de Carvalho CE; Brito LM; da Silva AB; Conde Júnior AM; de Carvalho FA; Carvalho AL
    Exp Parasitol; 2016 May; 164():49-55. PubMed ID: 26902606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carboxyl-modified poly(vinyl alcohol)-crosslinked chitosan hydrogel films for potential wound dressing.
    Zhang D; Zhou W; Wei B; Wang X; Tang R; Nie J; Wang J
    Carbohydr Polym; 2015 Jul; 125():189-99. PubMed ID: 25857974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol improves stability of amphotericin B nanoemulsion: promising use in the treatment of cutaneous leishmaniasis.
    Mansur-Alves I; Lima BLF; Santos TT; Araújo NF; Frézard F; Islam A; de Barros AL; Dos Santos DC; Fernandes C; Ferreira LA; Aguiar MM
    Nanomedicine (Lond); 2022 Aug; 17(18):1237-1251. PubMed ID: 36189757
    [No Abstract]   [Full Text] [Related]  

  • 39. Dissolving microneedle patches loaded with amphotericin B microparticles for localised and sustained intradermal delivery: Potential for enhanced treatment of cutaneous fungal infections.
    Peng K; Vora LK; Tekko IA; Permana AD; Domínguez-Robles J; Ramadon D; Chambers P; McCarthy HO; Larrañeta E; Donnelly RF
    J Control Release; 2021 Nov; 339():361-380. PubMed ID: 34619227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Field Efficacy of Topical Nano-Liposomal Amphotericin B (Sina Ampholeish®) Alone or in Combination with Glucantime® and Cryotherapy on Human Cutaneous Leishmaniasis.
    Alizadeh Z; Shirzadi MR; Hassanpour GR; Keshavarz H; Mohebali F; Eskandari SE; Zeinali M; Shirmohammad S; Mohebali M
    Iran J Parasitol; 2023; 18(4):419-426. PubMed ID: 38169758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.